Steve Sideris

4.5k total citations
19 papers, 963 citations indexed

About

Steve Sideris is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Steve Sideris has authored 19 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Steve Sideris's work include Computational Drug Discovery Methods (5 papers), Cancer therapeutics and mechanisms (4 papers) and Quinazolinone synthesis and applications (3 papers). Steve Sideris is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Cancer therapeutics and mechanisms (4 papers) and Quinazolinone synthesis and applications (3 papers). Steve Sideris collaborates with scholars based in United States, Singapore and United Kingdom. Steve Sideris's co-authors include Lili Chen, Claude Fauquet, Maureen C. Whalen, Pamela C. Ronald, Guo‐Liang Wang, Shiping Zhang, Shiva Malek, Kyle Elrod, Zhen Zhang and W. H. Song and has published in prestigious journals such as The Plant Cell, Journal of Molecular Biology and Analytical Chemistry.

In The Last Decade

Steve Sideris

19 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Sideris United States 15 578 270 128 127 120 19 963
S.H. Olesen United States 13 738 1.3× 120 0.4× 79 0.6× 231 1.8× 67 0.6× 15 1000
Stephanie Heinzlmeir Germany 19 790 1.4× 56 0.2× 81 0.6× 190 1.5× 82 0.7× 30 1.1k
Joakim E. Swedberg Australia 24 1.0k 1.8× 103 0.4× 221 1.7× 196 1.5× 65 0.5× 44 1.3k
Lilly Wong United States 19 591 1.0× 117 0.4× 46 0.4× 326 2.6× 59 0.5× 47 1.0k
Matthias Schmidt Germany 18 739 1.3× 71 0.3× 205 1.6× 244 1.9× 77 0.6× 44 981
Richard A. Norman United Kingdom 18 1.0k 1.8× 47 0.2× 325 2.5× 269 2.1× 165 1.4× 26 1.5k
Sina Sareth United States 8 621 1.1× 62 0.2× 68 0.5× 146 1.1× 50 0.4× 9 844
Jaroslav Veselý Czechia 8 674 1.2× 71 0.3× 196 1.5× 524 4.1× 64 0.5× 17 1.1k
Hans‐Dieter Pohlenz Germany 19 817 1.4× 116 0.4× 45 0.4× 76 0.6× 31 0.3× 29 1.3k
Will A. Stanley Germany 17 969 1.7× 164 0.6× 89 0.7× 132 1.0× 24 0.2× 27 1.2k

Countries citing papers authored by Steve Sideris

Since Specialization
Citations

This map shows the geographic impact of Steve Sideris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Sideris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Sideris more than expected).

Fields of papers citing papers by Steve Sideris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Sideris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Sideris. The network helps show where Steve Sideris may publish in the future.

Co-authorship network of co-authors of Steve Sideris

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Sideris. A scholar is included among the top collaborators of Steve Sideris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Sideris. Steve Sideris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Heffron, Timothy P., Chudi Ndubaku, Laurent Salphati, et al.. (2016). Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. ACS Medicinal Chemistry Letters. 7(4). 351–356. 76 indexed citations
2.
Hanan, Emily J., Marian C. Bryan, Yuan Chen, et al.. (2015). 4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 26(2). 534–539. 39 indexed citations
3.
Haling, Jacob R., Jawahar Sudhamsu, Ivana Yen, et al.. (2014). Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling. Cancer Cell. 26(3). 402–413. 176 indexed citations
4.
Fauber, Benjamin P., Peter S. Dragovich, Jinhua Chen, et al.. (2014). Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 24(24). 5683–5687. 17 indexed citations
5.
Gazzard, Lewis, B.A. Appleton, Kerry L. Chapman, et al.. (2014). Discovery of the 1,7-diazacarbazole class of inhibitors of checkpoint kinase 1. Bioorganic & Medicinal Chemistry Letters. 24(24). 5704–5709. 15 indexed citations
6.
Lee, Wendy, Daniel F. Ortwine, Philippe Bergeron, et al.. (2013). A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(18). 5097–5104. 26 indexed citations
7.
Estrada, Anthony A., Daniel G. Shore, Elizabeth Blackwood, et al.. (2013). Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR). Journal of Medicinal Chemistry. 56(7). 3090–3101. 25 indexed citations
8.
Lee, Ho‐June, Gabriele Schaefer, Timothy P. Heffron, et al.. (2012). Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M. Cancer Discovery. 3(2). 168–181. 68 indexed citations
9.
Yen, Ivana, Kyung Song, David Stokoe, et al.. (2009). Abstract B90: Understanding the effects of RAF inhibitors on RAF signaling in B-RAF V600E mutant versus wild type tumors. Molecular Cancer Therapeutics. 8(12_Supplement). B90–B90. 1 indexed citations
10.
Mavunkel, Babu, Yongjin Xu, Bindu Goyal, et al.. (2008). Pyrimidine-based inhibitors of CaMKIIδ. Bioorganic & Medicinal Chemistry Letters. 18(7). 2404–2408. 13 indexed citations
11.
Chen, Zheng, John Perumattam, Yongjin Xu, et al.. (2008). Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 3: Importance of the indole orientation. Bioorganic & Medicinal Chemistry Letters. 18(7). 2399–2403. 6 indexed citations
12.
Sydor, Jens, Mark Scalf, Steve Sideris, et al.. (2003). Chip-Based Analysis of Protein−Protein Interactions by Fluorescence Detection and On-Chip Immunoprecipitation Combined with μLC−MS/MS Analysis. Analytical Chemistry. 75(22). 6163–6170. 14 indexed citations
13.
Sydor, Jens, Maria Mariano, Steve Sideris, & Steffen Nock. (2002). Establishment of Intein-Mediated Protein Ligation under Denaturing Conditions:  C-Terminal Labeling of a Single-Chain Antibody for Biochip Screening. Bioconjugate Chemistry. 13(4). 707–712. 36 indexed citations
14.
Katz, B.A., Kyle Elrod, Christine Luong, et al.. (2001). A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees. Journal of Molecular Biology. 307(5). 1451–1486. 61 indexed citations
15.
Kuzmič, Petr, Kyle Elrod, Lynne Cregar, et al.. (2000). High-Throughput Screening of Enzyme Inhibitors: Simultaneous Determination of Tight-Binding Inhibition Constants and Enzyme Concentration. Analytical Biochemistry. 286(1). 45–50. 47 indexed citations
16.
Kuzmič, Petr, Steve Sideris, Lynne Cregar, et al.. (2000). High-Throughput Screening of Enzyme Inhibitors: Automatic Determination of Tight-Binding Inhibition Constants. Analytical Biochemistry. 281(1). 62–67. 48 indexed citations
17.
Elrod, Kyle, et al.. (1999). Expression and Characterization of Recombinant Mast Cell Tryptase. Protein Expression and Purification. 15(3). 251–257. 10 indexed citations
18.
Wang, Guo‐Liang, W. H. Song, Steve Sideris, et al.. (1998). Xa21D Encodes a Receptor-like Molecule with a Leucine-Rich Repeat Domain That Determines Race-Specific Recognition and Is Subject to Adaptive Evolution. The Plant Cell. 10(5). 765–779. 261 indexed citations
19.
Wang, Guo‐Liang, Deling Ruan, Wen‐Yuan Song, et al.. (1998). Xa21D Encodes a Receptor-Like Molecule with a Leucine-Rich Repeat Domain That Determines Race-Specific Recognition and Is Subject to Adaptive Evolution. The Plant Cell. 10(5). 765–765. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.H. Olesen Breakdown of academic impact, for papers by Stephanie Heinzlmeir Breakdown of academic impact, for papers by Joakim E. Swedberg Breakdown of academic impact, for papers by Lilly Wong Breakdown of academic impact, for papers by Matthias Schmidt Breakdown of academic impact, for papers by Richard A. Norman Breakdown of academic impact, for papers by Sina Sareth Breakdown of academic impact, for papers by Jaroslav Veselý Breakdown of academic impact, for papers by Hans‐Dieter Pohlenz Breakdown of academic impact, for papers by Will A. Stanley
Rankless by CCL
2026